Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00406913 · ClinicalTrials.gov registry record · NA
Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery
A NA study of Cataract Surgery and Prophylaxis, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 1
- Study location
NCT00406913: Completed NA study of Cataract Surgery and Prophylaxis, sponsored by University of Chicago.
NCT00406913 is a NA study of Cataract Surgery and Prophylaxis that has completed, run by University of Chicago. The registered enrollment target is 37 participants, below the 141-participant average among 7 other Cataract Surgery trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00406913, a NA study of Cataract Surgery and Prophylaxis, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the conjunctival flora prior to cataract or vitrectomy surgery comparing mupirocin ointment applied to the conjunctiva along with standard ocular sterilization vs. standard ocular sterilization alone.
Conditions Studied
Interventions
- DRUG mupirocin ointment
- OTHER SOC sterilization
Study Locations (1)
Illinois
- University of Chicago Hospitals - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2005-10 |
| Est. Completion | 2006-11 |
| Phase | NA |
What the finished NCT00406913 record still lists
NCT00406913 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 141-participant average among 7 other Cataract Surgery trials with a reported enrollment target (74% lower).
The record links to 3 conditions, with Cataract Surgery appearing as the primary indexed condition, and to 2 interventions - of which mupirocin ointment is the first listed.
NCT00406913 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00406913 about?
NCT00406913 is a clinical study titled "Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery". The purpose of this study is to evaluate the conjunctival flora prior to cataract or vitrectomy surgery comparing mupirocin ointment applied to the conjunctiva along with standard ocular sterilization vs. standard ocular sterilization alone.
What is the current status of trial NCT00406913?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2005-10. Estimated completion is 2006-11.
What conditions does trial NCT00406913 study?
This clinical trial studies the following conditions: Cataract Surgery, Prophylaxis, Endophthalmitis.
What interventions are being tested in trial NCT00406913?
The interventions under investigation include: mupirocin ointment (DRUG), SOC sterilization (OTHER).
Who is sponsoring clinical trial NCT00406913?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00406913 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Oral vs IV Sedation for Cataract Surgery in Older Adults
RECRUITING · Phase 4
-
Clinical Outcomes of Bilateral Clareon Vivity in Post-Refractive Patients
RECRUITING
-
Remimazolam for Cataract Surgery
RECRUITING · Phase 4
-
Efficacy and Safety of Bromfenac Ophthalmic Solution
COMPLETED · Phase 2
-
Omidria and Dexycu, or Omidria and Dextenza Compared to Topical Prednisolone Acetate 1% Following Cataract Surgery
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia